7 February 2024 false No description of principal activity Taxfiler 2024.6 15471199business:PrivateLimitedCompanyLtd2024-02-072025-02-28 154711992024-02-06 154711992024-02-072025-02-28 15471199business:AuditExempt-NoAccountantsReport2024-02-072025-02-28 15471199business:FilletedAccounts2024-02-072025-02-28 154711992025-02-28 15471199business:Director12024-02-072025-02-28 15471199business:RegisteredOffice2024-02-072025-02-28 15471199core:WithinOneYear2025-02-28 15471199core:ShareCapitalcore:PreviouslyStatedAmount2025-02-28 15471199core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-02-28 15471199core:PreviouslyStatedAmount2025-02-28 15471199business:SmallEntities2024-02-072025-02-28 15471199countries:EnglandWales2024-02-072025-02-28 iso4217:GBP xbrli:pure
Company Registration No. 15471199 (England and Wales)
Wyress Medical Consulting Limited Unaudited accounts for the period from 7 February 2024 to 28 February 2025
Wyress Medical Consulting Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Wyress Medical Consulting Limited Company Information for the period from 7 February 2024 to 28 February 2025
Director
Nkechi Alexia AGBALA
Company Number
15471199 (England and Wales)
Registered Office
164 Broadlands Avenue Enfield EN3 5AF England
Accountants
HARVEY & CO ACCOUNTANTS LIMITED Willesden Business Centre, 41 Willesden Lane London NW6 7RF
- 3 -
Wyress Medical Consulting Limited Statement of financial position as at 28 February 2025
2025 
Notes
£ 
Current assets
Debtors
4
2,507 
Cash at bank and in hand
1,598 
4,105 
Creditors: amounts falling due within one year
5
(3,991)
Net current assets
114 
Net assets
114 
Capital and reserves
Called up share capital
100 
Profit and loss account
14 
Shareholders' funds
114 
For the period ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 8 September 2025 and were signed on its behalf by
Nkechi Alexia AGBALA Director Company Registration No. 15471199
- 4 -
Wyress Medical Consulting Limited Notes to the Accounts for the period from 7 February 2024 to 28 February 2025
1
Statutory information
Wyress Medical Consulting Limited is a private company, limited by shares, registered in England and Wales, registration number 15471199. The registered office is 164 Broadlands Avenue, Enfield, EN3 5AF, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Debtors
2025 
£ 
Amounts falling due within one year
Other debtors
2,507 
5
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
3,991 
6
Average number of employees
During the period the average number of employees was 0.
- 5 -